NIH-funded research R01 grant

Effects of metformin during pregnancy on fetal development and long-term health

Official title: Metformin in Pregnancy: Fetal Consequences & Long-term offspring Outcomes in a NHP model

Funded at Oregon Health & Science University · NIH-11075494 · Data updated 2026-11-12

This study is looking at how taking metformin, a diabetes medication, during pregnancy might affect the growth and health of babies, helping us understand if it could lead to issues like obesity or insulin resistance as they grow up.

More Pregnancy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOregon Health & Science University
NIH-funded
Lab location1 site (Portland, United States)
Project startApril 19, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$1,731,929
NIH project number7R01DK128187-04
Project IDNIH-11075494 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include pregnant women who are prescribed metformin for conditions like gestational diabetes or polycystic ovary syndrome.

Less likely to help

Patients who are not pregnant or those who do not use metformin are unlikely to benefit from this research.

What this research studies

This research investigates how metformin, a medication commonly used for diabetes, affects fetal development and long-term health outcomes in offspring when taken by mothers during pregnancy. Using a non-human primate model, the study will compare the effects of metformin exposure versus a placebo from pre-pregnancy through lactation. The goal is to understand if metformin contributes to obesity and insulin resistance in children as they grow. This research aims to provide insights into the safety of metformin use in pregnant women and its implications for child health.

Why it matters

Potential benefit: If successful, this research could lead to better guidelines for the use of metformin in pregnant women, ensuring healthier outcomes for both mothers and their children.

How similar studies have gone: Previous research has indicated potential risks associated with metformin use during pregnancy, but this specific approach using a non-human primate model is novel.

Where this research is happening

  • Oregon Health & Science University
    Portland, United States
    Active

Researchers

  • Principal investigator: Kievit, Paul — Oregon Health & Science University
  • Study coordinator: Kievit, Paul

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.